Dr. Lynell W. Klassen, MD

Dr. Klassen practices at Nebraska Medical Center - Village Pointe - Outpatient Surgery Center - HOPD in Omaha, Nebraska.

Dr. Klassen's NPI, 1710936877, was assigned on May 8, 2006. Dr. Klassen graduated from University of Kansas School of Medicine - Kansas City in 1973. Dr. Klassen holds Nebraska license 16163.

Dr. Klassen's primary practice is Nebraska Medical Center - Village Pointe - Outpatient Surgery Center - HOPD, at 110 N 175th St, Omaha, NE 68118.

Dr. Klassen's primary practice is Nebraska Medical Center - Village Pointe - Outpatient Surgery Center - HOPD in Omaha, Nebraska. Dr. Klassen is also affiliated with Nebraska Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Klassen to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klassen practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Klassen's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Klassen is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Klassen's licenses on file in 2 states: Nebraska and Iowa.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Klassen treats.

CMS data shows 117 Medicare services from Dr. Klassen across 2 procedure codes in 2024, for 75 Medicare patients. Medicare paid $9,175 for them. Every service was in an office.

CMS counts 75 Medicare patients who saw Dr. Klassen in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Klassen's median patient age at 72, with 75% women.

In 2024, Dr. Klassen wrote 192 Medicare Part D claims for 88 patients. 97% of them were for generic drugs. CMS names the drug for 138 of them, across 5 drugs with 11 or more claims each, at $2,642 in total drug cost. In 2023, CMS named 1,046 claims across 21 drugs.

Dr. Klassen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 79 papers to Dr. Klassen, published from 2008 to 2020. 2017 was the busiest year, with 4. The most frequent topics are Acetaldehyde, Malondialdehyde and Arthritis, Rheumatoid. Dr. Klassen has published most often in Alcohol Clin Exp Res. Dr. Klassen's most frequent co-authors are Daniel R. Anderson, MD, Ted R. Mikuls, MD and Michelene Payne Hearth-Holmes, MD.

Dmand AI links Dr. Klassen to 3 clinical trials. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Bristol-Myers Squibb sponsors the most, 3. Open Payments lists research payments to Dr. Klassen that name 3 trials.

CMS Open Payments shows 83 general payments to Dr. Klassen from 11 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $67,200. It also lists 12 research payments totaling $22,750 from 2017 to 2024, naming 3 clinical trials.

Dmand AI lists 4 awards for Dr. Klassen, most recently Regional Top Doctor in 2014.

Dr. Klassen graduated from University of Kansas School of Medicine - Kansas City in 1973. Dr. Klassen is a member of ACP and ACR.

Dr. Klassen is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.